Highlights • Lung fibrosis is an emerging complication of SARS-CoV-2 infection. • Exertional desaturation may be present in treated COVID-19 patients at discharge. • A 6-minute walk test may be of prognostic value on COVID patients at discharge. SARS-COV-2 has created one of the most massive pandemics in modern history. There is a rapid accumulation of data on its epidemiology, clinical course, diagnosis, management, and complications. One of the sequelae of COVID-19 pneumonia and acute respiratory distress syndrome (ARDS) is pulmonary fibrosis. There is a dearth of accurate data on the prevalence of pulmonary fibrosis post-COVID-19. We report a patient who developed dyspnea secondary to pulmonary fibrosis after successful treatment of COVID-19 pneumonia.
【저자키워드】 COVID-19, severe acute respiratory syndrome coronavirus 2, SARS-CoV-2, ARDS, acute respiratory distress syndrome, pulmonary fibrosis, coronavirus infection 2019, Dyspnea, 【초록키워드】 Treatment, Pneumonia, Epidemiology, SARS-COV-2 infection, Diagnosis, fibrosis, discharge, Prevalence, Clinical course, Desaturation, management, Patient, Pandemics, complications, acute respiratory distress, 6-minute walk test, COVID-19 patient, Prognostic value, syndrome, treated, COVID patient, 【제목키워드】 SARS-COV-2 infection, fibrosis,